ArroHealth Revenue and Competitors

Hauppauge, NY USA

Location

$70.6M

Total Funding

Technology

Industry

Estimated Revenue & Valuation

  • ArroHealth's estimated annual revenue is currently $42.1M per year.(i)
  • ArroHealth's estimated revenue per employee is $217,150
  • ArroHealth's total funding is $70.6M.

Employee Data

  • ArroHealth has 194 Employees.(i)
  • ArroHealth grew their employee count by 0% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.3M1138%N/AN/A
#2
$0.9M90%N/AN/A
#3
$3.4M24-14%N/AN/A
#4
$31.6M1427%N/AN/A
#5
$0.6M60%N/AN/A
#6
$20.6M102-3%N/AN/A
#7
$4.1M294%N/AN/A
#8
$3.3M2310%N/AN/A
#9
$16.6M82-22%$35MN/A
#10
$1.2M10-9%N/AN/A
Add Company

Since inception, MedSave has applied innovative thinking, proprietary technology, and a client-focused business model to become a leader in a wide range of healthcare services. Today our services include: Risk adjustment - retrospective and prospective Managed care administration Medical record retrieval and coding services Record retrieval for litigation and insurance Third party administration for employer health plans International healthcare cost management services

keywords:N/A

$70.6M

Total Funding

194

Number of Employees

$42.1M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

ArroHealth News

2022-04-19 - Quality and Safety Reporting System for Healthcare Market ...

... The Patient Safety, Riskonnect, Datix, PowerHealth Solutions, Episource, Binary Fountain, Ventiv Technology, ArroHealth, Advantmed.

2017-04-19 - New Mountain Capital-backed Ciox Health Acquires ArroHealth

ALPHARETTA, Ga.–(BUSINESS WIRE)–New Mountain Capital and Ciox Health today announced the acquisition of ArroHealth, a leading provider of chart retrieval and risk adjustment services for health plans and provider groups. This merger will strengthen Ciox’s ability to deliver workflow-driven proce ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$68.1M1950%N/A
#2
$66.7M1976%N/A
#3
$56.5M215-2%N/A
#4
$63.8M2329%N/A
#5
$76.6M2408%N/A